Clinical Trials Browser

Phase 1/2 × Multiple Myeloma × obatoclax × Clear all

NCT00719901 2015-01-12

Obatoclax and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Terminated

11 enrolled 9 charts

Multiple Myeloma